(Q36063859)

11 August 2017

1 reference

title

Methotrexate in systemic lupus erythematosus. (English)

1 reference

systemic lupus erythematosus

11 August 2017

1 reference

0 references

author name string

J M Wong

series ordinal

1

1 reference

PubMed ID

15751813

11 August 2017

J M Esdaile

series ordinal

2

1 reference

11 August 2017

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

14

1 reference

11 August 2017

2

1 reference

11 August 2017

101-105

1 reference

Methotrexate therapy in systemic lupus erythematosus

11 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2043RR

Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2043RR

Methotrexate use in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2043RR

The use of methotrexate in steroid-resistant systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2043RR

A conceptual framework for clinical trials in SLE and other multisystem diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2043RR

Sample size considerations for superiority trials in systemic lupus erythematosus (SLE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2043RR

Randomized discontinuation trials: Utility and efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2043RR

10.1191/0961203305LU2043RR

21 January 2018

Identifiers

DOI

1 reference

release_fnr3tc3j25asfk3atxiojt62mm

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fnr3tc3j25asfk3atxiojt62mm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15751813

1 reference

PubMed ID

15751813